Year |
Citation |
Score |
2020 |
Ntellas P, Mavroeidis L, Gkoura S, Gazouli I, Amylidi AL, Papadaki A, Zarkavelis G, Mauri D, Karpathiou G, Kolettas E, Batistatou A, Pentheroudakis G. Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer. Cancers. 12. PMID 33121034 DOI: 10.3390/cancers12113145 |
0.343 |
|
2017 |
Biziota E, Mavroeidis L, Hatzimichael E, Pappas P. Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation. Cancer Letters. 400: 243-251. PMID 28017892 DOI: 10.1016/j.canlet.2016.12.018 |
0.355 |
|
Low-probability matches (unlikely to be authored by this person) |
2019 |
Pentheroudakis G, Mavroeidis L, Papadopoulou K, Koliou GA, Bamia C, Chatzopoulos K, Samantas E, Mauri D, Efstratiou I, Pectasides D, Makatsoris T, Bafaloukos D, Papakostas P, Papatsibas G, Bombolaki I, et al. Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab. Clinical Colorectal Cancer. PMID 31402291 DOI: 10.1016/j.clcc.2019.07.007 |
0.233 |
|
2020 |
Mauri D, Gazouli I, Zarkavelis G, Papadaki A, Mavroeidis L, Gkoura S, Ntellas P, Amylidi AL, Tsali L, Kampletsas E. Chemotherapy Associated Ovarian Failure. Frontiers in Endocrinology. 11: 572388. PMID 33363515 DOI: 10.3389/fendo.2020.572388 |
0.191 |
|
2020 |
Zarkavelis G, Mauri D, Karassa F, Eleftherios K, Pentheroudakis G, Pappadaki A, Mavroeidis L, Ntellas P, Gkoura S, Gazouli I. The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature. Contemporary Oncology (Poznan, Poland). 24: 75-78. PMID 32514241 DOI: 10.5114/wo.2020.94727 |
0.13 |
|
2018 |
Mavroeidis L, Metaxa-Mariatou V, Papoudou-Bai A, Lampraki AM, Kostadima L, Tsinokou I, Zarkavelis G, Papadaki A, Petrakis D, Gκoura S, Kampletsas E, Nasioulas G, Batistatou A, Pentheroudakis G. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of / genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece. Esmo Open. 3: e000335. PMID 29636989 DOI: 10.1136/esmoopen-2018-000335 |
0.129 |
|
2020 |
Mavroeidis L, Vassou A, Zarkavelis G, Papadaki A, Mouzaki I, Ntellas P, Gkoura S, Gazouli I, Pentheroudakis G. Acquired Hemophilia in an Elderly Patient with Carcinoma of the Ampulla of Vater. Case Reports in Oncology. 13: 1-6. PMID 32110212 DOI: 10.1159/000504338 |
0.112 |
|
2020 |
Rauh S, Mavroeidis L, Ntellas P, Gazouli I, Gkoura S, Papadaki A, Mauri D, Metaxas Y, Douillard JY, Pentheroudakis G. Old drug, new clinical use, no man's land for the indication: an awareness call from European experts. Esmo Open. 5: e000615. PMID 33551069 DOI: 10.1136/esmoopen-2019-000615 |
0.099 |
|
2015 |
Biziota E, Briasoulis E, Mavroeidis L, Marselos M, Harris AL, Pappas P. Cellular and molecular effects of metronomic vinorelbine and 4-O-deacetylvinorelbine on human umbilical vein endothelial cells. Anti-Cancer Drugs. PMID 26629767 DOI: 10.1097/CAD.0000000000000319 |
0.087 |
|
2021 |
Gazouli I, Tsampalas S, Tsimaris I, Zarkavelis G, Grivas N, Kampletsas E, Papadaki A, Mavroeidis L, Ntellas P, Gkoura S, Tsali L, Amylidi AL, Vlachou MS, Mauri D. Ureteral carcinoma metastasizing to the testicle: Can misdiagnosis of orchiepididymitis be avoided? Urology Annals. 13: 86-88. PMID 33897173 DOI: 10.4103/UA.UA_124_20 |
0.069 |
|
2021 |
Mauri D, Kampletsas E, Smyris G, Tsali L, Tsekeris P, Harissis H, Kamposioras K, Tolia M, Hyphantis T, Ntellas P, Gazouli I, Zarkavelis G, Mavroeidis L, Amylidi AL, Torounidou N, et al. Interior Design: A New Perspective in Supportive Care of Patients with Acute Onset of Debilitating Diseases. Palliative Medicine Reports. 2: 365-368. PMID 35983237 DOI: 10.1089/pmr.2021.0031 |
0.059 |
|
Hide low-probability matches. |